India's High Court Blocks Novartis Patent, Boosting Generics
India's highest court on Monday shot down Novartis AG's bid to patent blockbuster cancer drug Glivec after finding it's highly similar to an old version of the medication, a decision that...To view the full article, register now.
Already a subscriber? Click here to view full article